examples of glp 1 receptor agonists GLP-1 for individualized treatment type 2 diabetes mellitus PDB-101: Molecule of the Month:

The most obvious symptoms of PD in the early stages are tremor, limb stiffness, decreased motor function and abnormal gait

Associating GLP- 1 or glucagon receptor agonists with core hormones like estrogens, thyroid hormones, and dexamethasone was the strategy employed (reviewed in [137, 138])

Generally, single use will not lead to hypoglycemia, but if combined with sulfonylureas or insulin, attention should be paid to prevent hypoglycemia (142)

Novo Nordisk also stated that it retains 60% of the cost and the other 40% goes to middlemen in the complex US health system

DOI: Published online: July 1, 2025 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Corresponding author: Hye Jin Yoo Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited